| Literature DB >> 34158102 |
Addisu A Yegoraw1,2, Awol M Assen3,4, Priscilla F Gerber3, Stephen W Walkden-Brown3.
Abstract
Understanding the mechanisms of transmission of infectious laryngotracheitis virus (ILTV) is critical to proper control as both vaccine and wild-type strains circulate within chicken flocks with potential adverse consequences. The relative efficiency of transmission by direct contact between chickens and airborne transmission has not been investigated. Furthermore, relatively high levels of ILTV DNA have been detected in poultry dust and blood but the infectivity of these is unknown. In this study, comparison of in-contact and airborne transmission of two vaccine and one field strain of ILTV revealed that all transmitted to 100% of in-contact birds by 6 days post-exposure (dpe). Airborne transmission without contact resulted in 100% transmission by 14 and 17 dpe for the wild-type and Serva vaccine virus but only 27% transmission by 21 dpe for the A20 vaccine virus. The infectivity of dust or extracts of dust and blood or plasma from infected chickens at various stages of infection was assessed by inoculation into susceptible chickens. There was no transmission by any of these materials. In conclusion, direct contact facilitated efficient ILTV transmission but the virus was unable to be transmitted by dust from infected chickens suggestive of a limited role in the epidemiology of ILTV.Entities:
Keywords: Airborne; Contact; Dust; Infectious laryngotracheitis virus; Meat chickens; Transmission; Vaccine
Year: 2021 PMID: 34158102 PMCID: PMC8220770 DOI: 10.1186/s13567-021-00959-1
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Details of the experiments: dose, mode of exposure and type of inoculum used in each experiment
| Experiment | Treatment | Isolator (n) | Chickens/isolator (n) | ILTV strain | Inoculum | Mode of exposure | Dose | Age at exposure (d) |
|---|---|---|---|---|---|---|---|---|
| Expt. 1 CONTACT | Eye drop (donors) | 3 | 8 | A20 Serva C9 | Virus | Eye drop | a103.5 PFU/bird (A20) 102.8 EID/bird (Serva) 104TCID50/bird (Class 9) | 14 |
| In-contact | 3 | 8 | A20 Serva C9 | Nil | Contact with donors | |||
| Shared air space | 3 | 16 | A20 Serva C9 | Nil | Shared air with donors | |||
| Expt. 2 DUST INF | 3 dpe dust | 2 | 15 | C9 | Dust or dust extract | Eye/URTb | 60 µL extract, 5–10 mg dust | 10 |
| 7 dpe dust | 2 | 15 | C9 | 14 | ||||
| 14 dpe dust | 2 | 15 | C9 | 21 | ||||
| Expt. 3 BLOOD INF | A20 | 1 | 15 | A20 | Plasma + fresh whole bloodd | Eye/intra coelemicc | 60 µL plasma + 1 mL blood | 20 & 24 |
| Serva | 1 | 15 | Serva | |||||
| Class 9 | 1 | 15 | C9 | |||||
| Control | Normal saline | 2 | 16–17 | - | Normal saline | Eye drop | - | 7 |
C9, class 9; URT, upper respiratory tract.
aDose for eye drop infection of donor birds only.
bExtract administered by eye drop (n = 15), dust insufflated into nares (n = 5), laryngopharyngeal space (n = 5) or trachea (n = 5).
cPlasma and whole fresh blood collected at 6 and 10 dpe of infected birds.
dPlasma administered by eye drop and whole fresh blood by intra-coelemic (“abdominal”) injection to the same chicken.
Details of the dose and batch number of ILTV used for the different groups
| ILTV strain | Classification | Batch number | Dose administered by eye drop |
|---|---|---|---|
| NSW/18 B2 (Class 9) | Virulent wild-type | B2P3_20180614 | 104TCID50/bird and 103TCID50/bird |
| Serva | Vaccine | B.1707904 | 102.8 EID/bird |
| A20 | Vaccine | B3.44135 | 103.5 PFU/bird |
EID: embryo infective dose, PFU: plaque forming unit, TCID: tissue culture infective dose.
Experiment 1 CONTACT. Summary of analyses of clinical scores and ILTV GC in choanal cleft swabs (LSM ±S.E) showing treatment effects and their significance
| Factors and levels | Clinical signs | qPCR result of choanal cleft swabs | ||
|---|---|---|---|---|
| N.positive/total (%) | Clinical score | N.positive/total (%) | Log10 GC/reaction | |
| Overall | 45/92 (49) | 0.23 ± 0.04 | 81/92 (88) | 4.23 ± 0.09 |
| Factor and level | ||||
| Mode of exposure | ||||
| Eye drop | 14/23 (61)a | 0.35 ± 0.05a | 23/23 (100)a | 5.02 ± 0.16a |
| In-contact | 17/23 (74)a | 0.39 ± 0.05a | 23/23 (100)a | 4.78 ± 0.16a |
| Shared airspace | 14/46 (30)b | 0.09 ± 0.04b | 35/46 (76)b | 2.89 ± 0.12b |
| ILTV Strains | ||||
| A20 | 2/29 (7)c | 0.02 ± 0.05c | 18/29 (62)b | 3.95 ± 0.16a |
| Serva | 18/32 (56)b | 0.27 ± 0.05b | 32/32 (100)a | 4.39 ± 0.15a |
| Class 9 | 25/31 (81)a | 0.55 ± 0.05a | 31/31 (100)a | 4.35 ± 0.15a |
| dpe | ||||
| 3 | – | – | 2.86 ± 0.16b | |
| 5 | 6/95 (6) | 0.1 ± 0.05c | – | |
| 6 | 13/95 (14) | 0.21 ± 0.05bc | 4.65 ± 0.16a | |
| 7 | 13/95 (14) | 0.21 ± 0.05bc | – | |
| 8 | 20/95 (21) | 0.33 ± 0.05ab | – | |
| 9 | 21/95 (22) | 0.44 ± 0.05a | – | |
| 10 | 16/95 (17) | 0.28 ± 0.05abc | 4.69 ± 0.16a | |
| 11 | 21/95 (22) | 0.39 ± 0.05ab | – | |
| 13 | 15/95 (16) | 0.29 ± 0.05ab | – | |
| 14 | 17/95 (18) | 0.26 ± 0.05abc | 4.35 ± 0.16a | |
| 15 | 21/95 (22) | 0.32 ± 0.05ab | – | |
| 16 | 18/95 (19) | 0.28 ± 0.05abc | – | |
| 17 | 16/95 (17) | 0.26 ± 0.05abc | 4.31 ± 0.16a | |
| 18 | 21/95 (22) | 0.26 ± 0.05abc | – | |
| 21 | 23/95 (24) | 0.29 ± 0.05ab | 4.51 ± 0.16a | |
| Interaction ( | ||||
| ILTV strain*Dpe | ||||
| ILTV strains*ME | ||||
| Mode of exposure*Dpe | ||||
| ILTV strains*ME*Dpe | ||||
Summary of analyses of clinical scores and ILTV GC in choanal cleft swabs (LSM ± S.E) showing treatment effects and their significance.
*dpe: days post-exposure, GC: genome copy, ME: mode of exposure.
abcDifferent letters within columns for each factor indicate significant differences between levels (P < 0.05). Bold text indicates statistically significant values (P < 0.05).
Experiment 1 CONTACT
| ILTV strains | Clinical sign | Proportion of chickens (%) showing ILT clinical signs by mode of exposure | |||
|---|---|---|---|---|---|
| Eye drop (%) | In- contact (%) | Shared airspace (%) | All modes of exposure | ||
| A20 | Conjunctivitis | 0/7 (0.00) | 2/7 (28.6) | 0/15 (0.00) | 2/29 (7) |
| Respiratory signs | 0/7 (0.00) | 0/7 (0.00) | 0/15 (0.00) | 0/29 (0.00) | |
| Demeanour | 0/7 (0.00) | 0/7 (0.00) | 0/15 (0.00) | 0/29 (0.00) | |
| Any clinical signs | 0/7 (0.00) | 2/7 (29) | 0/15 (0.00) | 2/29 (7) | |
| Serva | Conjunctivitis | 6/8 (75)abA | 7/8 (87.5)a | 5/16 (31.3)b | 18/32 (56)A |
| Respiratory signs | 0/8 (0.00)B | 0/8 (0.00) | 0/16 (0.00) | 0/32 (0.00)B | |
| Demeanour | 0/8 (0.00)aB | 1/8 (12.5) | 0/16 (0.00) | 1/32 (3)B | |
| Any clinical signs | 6/8 (75)ab | 7/8 (88)a | 5/16 (31)b | 18/32 (56) | |
| Class 9 | Conjunctivitis | 8/8 (100)aA | 8/8 (100)aA | 7/15 (46.7)bA | 23/31 (74)A |
| Respiratory signs | 0/8 (0.00)B | 2/8 (25)B | 2/15 (13.3)B | 4/31 (13)B | |
| Demeanour | 0/8 (0.00)B | 1/8 (12.5)B | 0/15 (0.00)B | 1/31 (3)B | |
| Any clinical signs | 8/8 (100) | 8/8 (100) | 9/15 (60) | 25/31 (81) | |
Type and frequency of clinical signs observed over the full period of 21 dpe showing interaction between the effects of ILTV strain and mode of exposure.
abDifferent lowercase superscripts indicate significant differences within rows.
ABUppercase superscripts indicate a significant differences within columns for each ILTV strain.
Figure 1Experiment 1 CONTACT. Interaction between the effects of mode of infection, ILTV strain, and days post-exposure on the severity of clinical scores. Each point represents a chicken on a given dpe.
Figure 2Experiment 1 (CONTACT). Individual bird profiles of ILTV GC detected in choanal cleft swabs, by ILTV strain, route of transmission and dpe.
Figure 3Experiment 1 (CONTACT). Viral load of A20, Serva and Class 9 in choanal cleft swabs (log10 GC/reaction, LSM ± SE) showing the interacting effects of ILTV strain, mode of exposure and dpe. Solid lines represent the eye drop inoculated birds and the dashed lines represent the in-contact and shared airspace exposed birds.
Experiment 1 CONTACT. Proportion of birds becoming infected with ILTV following exposure to A20, Serva and Class 9 ILTV by eye drop inoculation, contact with inoculated birds or sharing an airspace with inoculated in the 21 days post exposure
| ILTV strains | Proportion of chickens infected with ILTV (%)* | |||
|---|---|---|---|---|
| Eye drop | In-contact | Shared airspace | Total | |
| A20 | 7/7 (100)a | 7/7 (100)a | 4/15 (27)bA | 18/29 (62)A |
| Serva | 8/8 (100) | 8/8 (100) | 16/16 (100)B | 32/32 (100)B |
| Class 9 | 8/8 (100) | 8/8 (100) | 15/15 (100)B | 31/31 (100)B |
| Total | 23/23 (100) | 23/23 (100) | 35/46 (76) | 81/92 (88) |
| Factor | ||||
| ILTV strain | < 0.0001 | |||
| Mode of exposure | 0.0019 | |||
Proportion of birds becoming infected with ILTV following exposure to A20, Serva and Class 9 ILTV by eye drop inoculation, contact with inoculated birds or sharing an airspace with inoculated in the 21 dpe.
*As defined in “Materials and methods” section.
abDifferent lowercase superscripts indicate significant differences within rows.
ABUppercase superscripts indicate a significant differences within columns for each ILTV strain. (P < 0.05).
Figure 4Experiment 1 CONTACT. Proportion of chickens becoming infected with ILTV strains, A20, Serva and Class 9 over time following different modes of exposure. P values are based on Kaplan–Meier survival analysis.